MARKET IS OPEN
Loading latest tickers...
Market Indices
S&P 500
$7,666.45
+0.19%
NASDAQ 100
$30,501.56
+0.31%
DOW JONES
$50,927.00
+0.04%
NASDAQ Composite
$26,871.60
+0.04%
RUSSELL 2000
$2,790.20
+0.41%
CBOE VIX
$16.39
+0.31%
Sector Heatmap
Technology+1.05%
Financials+0.11%
Healthcare-1.32%
Consumer Cycl-0.03%
Consumer Staples-0.33%
Energy+1.95%
Industrials+0.99%
Materials-0.33%
Real Estate-0.56%
Utilities+0.61%
Comm Services-0.93%
ALDX — Aldeyra Therapeutics, Inc.
NasdaqAldeyra Therapeutics, Inc.
$1.29
+0.06(+4.88%)
- O
- 1.26
- H
- 1.31
- L
- 1.20
- V
- 1.16M
⏱️ End-of-day dataAs of Oct 1, 2026
ALDX — Financial Statements
Historical 2-Year Statements| Financial Metric / Line Item | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|
| Fiscal Date | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Period | quarterly | quarterly | quarterly | quarterly | quarterly | quarterly |
| Year | 2,026.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,024.00 |
| Cash | $24.15M | $29.57M | $20.32M | $17.50M | $26.37M | $23.73M |
| Cash Equivalents | $40.85M | $40.47M | $39.02M | $23.74M | $23.98M | $30.79M |
| Cash And Cash Equivalents | $65.00M | $70.04M | $59.34M | $41.24M | $50.35M | $54.53M |
| Prepaid Assets | 105,074.00 | 407,194.00 | 721,650.00 | $1.03M | 141,059.00 | 408,091.00 |
| Other Current Assets | 270,429.00 | 291,922.00 | 306,507.00 | 193,487.00 | 332,282.00 | 301,152.00 |
| Total Current Assets | $66.27M | $71.78M | $77.46M | $84.56M | $92.73M | $10.41M |
| Properties | 209,262.00 | 275,861.00 | 340,977.00 | 404,660.00 | 466,942.00 | 266,955.00 |
| Total Non Current Assets | 209,262.00 | 275,861.00 | 340,977.00 | 404,660.00 | 466,942.00 | 534,216.00 |
| Total Assets | $66.48M | $72.06M | $77.80M | $84.96M | $93.20M | $10.46M |
| Accounts Payable | 141,356.00 | 158,461.00 | 13,423.00 | $1.46M | 346,146.00 | 180,453.00 |
| Accrued Expenses | $1.32M | $1.85M | $2.52M | $3.50M | $3.42M | $7.79M |
| Short Term Debt | $15.51M | $15.53M | $15.47M | $15.41M | 255,342.00 | 303,003.00 |
| Deferred Revenue | $6.00M | $6.00M | $6.00M | $6.00M | $6.00M | $6.00M |
| Pensions | $1.35M | $4.27M | $4.48M | $3.16M | $4.26M | $4.33M |
| Total Current Liabilities | $24.33M | $27.81M | $28.48M | $29.53M | $14.29M | $18.60M |
| Total Non Current Liabilities | 0.00 | 0.00 | 72,536.00 | 143,447.00 | $15.31M | $15.00M |
| Total Liabilities | $24.33M | $27.81M | $28.56M | $29.67M | $29.60M | $33.60M |
| Common Stock | 60,321.00 | 60,163.00 | 60,163.00 | 60,046.00 | 60,046.00 | 59,648.00 |
| Retained Earnings | $-48.74M | $-48.40M | $-47.75M | $-46.98M | $-46.00M | $-45.01M |
| Total Shareholders Equity | $42.16M | $44.25M | $49.24M | $55.29M | $63.60M | $71.00M |
| Additional Paid In Capital | $52.95M | $52.81M | $52.67M | $52.50M | $52.36M | $52.10M |
| Other Short Term Investments | N/A | 0.00 | $15.96M | $40.68M | $39.71M | $46.62M |
| Other Non Current Assets | N/A | 0.00 | 0.00 | 0.00 | 0.00 | 267,261.00 |
| Other Shareholders Equity | N/A | 0.00 | 815.00 | -10,995.00 | 1,598.00 | 37,442.00 |
| Long Term Debt | N/A | N/A | 72,536.00 | 143,447.00 | $15.31M | $15.00M |
| Other Receivables | N/A | N/A | N/A | N/A | 755,545.00 | N/A |